Considerations in Treatment Planning for Esophageal Cancer

Seminars in Radiation Oncology

Volumn 17, Issue 1, 2007, Pages 53-61

  Hong, Theodore S ^a   Crowley, Elizabeth M ^a   Killoran, Joseph ^b   Mamon, Harvey J ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

esophageal cancer; IMRT; normal tissue tolerance; PET scanning; treatment planning

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGUS CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PNEUMONIA; TREATMENT PLANNING;

ESOPHAGEAL NEOPLASMS; HUMANS; LUNG; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33845507089     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2006.09.001     Document Type: Article

References (44)

1. Jemal A., Tiwari R.C., Murray T., et al. Cancer statistics, 2004. CA Cancer J Clin 54 (2004) 8-29
2. Hulscher J.B., van Sandick J.W., de Boer A.G., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347 (2002) 1662-1669
3. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial. Lancet 359 (2002) 1727-1733
4. Walsh T.N., Noonan N., Hollywood D., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335 (1996) 462-467
5. Herskovic A., Martz K., al-Sarraf M., et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326 (1992) 1593-1598
6. Hosch S.B., Stoecklein N.H., Pichlmeier U., et al. Esophageal cancer: The mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol 19 (2001) 1970-1975
7. Minsky B.D., Neuberg D., Kelsen D.P., et al. Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 43 (1999) 517-523
8. Minsky B.D., Pajak T.F., Ginsberg R.J., et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol 20 (2002) 1167-1174
9. Bosset J.F., Gignoux M., Triboulet J.P., et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337 (1997) 161-167
10. Urba S.G., Orringer M.B., Turrisi A., et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 (2001) 305-313
11. Krasna M., Tepper J.E., Niedzwiecki D., et al. Trimodality therapy is superior to surgery alone in esophageal cancer: Results of CALGB 9781 (2006) Paper presented at: ASCO 2006 Gastrointestinal Cancers Symposium, San Francisco, California, January 26-28
12. Kwa S.L., Theuws J.C., Wagenaar A., et al. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol 48 (1998) 61-69
13. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 54 (2002) 329-339
14. Oetzel D., Schraube P., Hensley F., et al. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 33 (1995) 455-460
15. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
16. Hernando M.L., Marks L.B., Bentel G.C., et al. Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51 (2001) 650-659
17. Lingos T.I., Recht A., Vicini F., et al. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 21 (1991) 355-360
18. Law S., Wong K.H., Kwok K.F., et al. Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 240 (2004) 791-800
19. Wang S.L., Liao Z., Vaporciyan A.A., et al. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 64 (2006) 692-699
20. Chandra A., Guerrero T.M., Liu H.H., et al. Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. Radiother Oncol 77 (2005) 247-253
21. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Lancet 355 (2000) 1757-1770
22. Ng A.K., Bernardo M.P., Weller E., et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 20 (2002) 2101-2108
23. Eriksson F., Gagliardi G., Liedberg A., et al. Long-term cardiac mortality following radiation therapy for Hodgkin's disease: Analysis with the relative seriality model. Radiother Oncol 55 (2000) 153-162
24. Pera M., Manterola C., Vidal O., et al. Epidemiology of esophageal adenocarcinoma. J Surg Oncol 92 (2005) 151-159
25. Lavrenkov K., Partridge M., Cook G., et al. Positron emission tomography for target volume definition in the treatment of non-small cell lung cancer. Radiother Oncol 77 (2005) 1-4
26. Nishioka T., Shiga T., Shirato H., et al. Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys 53 (2002) 1051-1057
27. Leong T., Everitt C., Yuen K., et al. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol 78 (2006) 254-261
28. Moureau-Zabotto L., Touboul E., Lerouge D., et al. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. Int J Radiat Oncol Biol Phys 63 (2005) 340-345
29. Konski A., Doss M., Milestone B., et al. The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 1123-1128
30. Vrieze O., Haustermans K., De Wever W., et al. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?. Radiother Oncol 73 (2004) 269-275
31. van Westreenen H.L., Heeren P.A., Jager P.L., et al. Pitfalls of positive findings in staging esophageal cancer with F-18-fluorodeoxyglucose positron emission tomography. Ann Surg Oncol 10 (2003) 1100-1105
32. Lowe V.J., Booya F., Fletcher J.G., et al. Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol 7 (2005) 422-430
33. Shrikanthan S., Aydin A., Dhurairaj T., et al. Intense esophageal FDG activity caused by Candida infection obscured the concurrent primary esophageal cancer on PET imaging. Clin Nucl Med 30 (2005) 695-697
34. Bural G.G., Kumar R., Mavi A., et al. Reflux esophagitis secondary to chemotherapy detected by serial FDG-PET. Clin Nucl Med 30 (2005) 182-183
35. Weber W.A., Ott K., Becker K., et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 19 (2001) 3058-3065
36. Downey R.J., Akhurst T., Ilson D., et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: Results of a prospective trial. J Clin Oncol 21 (2003) 428-432
37. Song S.Y., Kim J.H., Ryu J.S., et al. FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1053-1059
38. Wieder H.A., Beer A.J., Lordick F., et al. Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction. J Nucl Med 46 (2005) 2029-2034
39. Westerterp M., van Westreenen H.L., Reitsma J.B., et al. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy-systematic review. Radiology 236 (2005) 841-851
40. Hong D, Lunagomez S, Kim EE, et al: Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma. Cancer 104:1620-1626, 15
41. Jarritt P., Hounsell A., Carson K., et al. Use of combined PET/CT images for radiotherapy planning: Initial experiences in lung cancer. Br J Radiol 28 suppl (2005) S33-S40
42. Mell L.K., Roeske J.C., and Mundt A.J. A survey of intensity-modulated radiation therapy use in the United States. Cancer 98 (2003) 204-211
43. Wu Q., Mohan R., Morris M., et al. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: Dosimetric results. Int J Radiat Oncol Biol Phys 56 (2003) 573-585
44. Fu W.H., Wang L.H., Zhou Z.M., et al. Comparison of conformal and intensity-modulated techniques for simultaneous integrated boost radiotherapy of upper esophageal carcinoma. World J Gastroenterol 10 (2004) 1098-1102